GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

U.S. officials have argued that Europe should be paying more for drugs to help lower Americans' prices. But whether they have ...

President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

Access to care could be affected, following HHS indication that it will not enforce updates adopted in 2024 to the mental ...

Dive into top trends shaping the biopharma industry with STAT and experts, who will share practical insights and ...

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

Hospitals pay provider taxes, helping states spend more on Medicaid and increase the amounts paid by the federal government.

Pope Francis was hospitalized for more than five weeks. A pneumonia riddled both of his lungs, and his doctors thought he was ...

UnitedHealth Group CEO Andrew Witty abruptly stepped down from the health insurance and care conglomerate on Tuesday, citing ...

A small but powerful nugget is buried in the text of the House budget reconciliation bill released this week: A clause that ...

The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...